OSE Immunotherapeutics S.A.

OSE Immunotherapeutics S.A.verified

OSE.PA

Price:

$4.912

Market Cap:

$110.24M

OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; CoVepiT, a prophylactic vaccine against the SARS-CoV-2 virus; BI 765063, which is in Phase I clinical trial to treat solid tumors; and BiCKI, a novel bispecific checkpoint inhibitor platform, targeting PD-1 and innovative targets to fight primary and secondary resistance mechanisms developed by cancers. The company's products also comprise OSE-12...[Read more]

Industry

Biotechnology

IPO Date

2015-03-30

Stock Exchange

PAR

Ticker

OSE.PA

The ROE as of December 2025 (TTM) for OSE Immunotherapeutics S.A. (OSE.PA) is -60.89%

According to OSE Immunotherapeutics S.A.’s latest financial reports and current stock price. The company's current ROE is -60.89%. This represents a change of 523.39% compared to the average of -9.77% of the last 4 quarters.

OSE Immunotherapeutics S.A. (OSE.PA) Historical ROE (quarterly & annually)

How has OSE.PA ROE performed in the past?

The mean historical ROE of OSE Immunotherapeutics S.A. over the last ten years is -18.35%. The current -60.89% ROE has changed 231.93% with respect to the historical average. Over the past ten years (40 quarters), OSE.PA's ROE was at its highest in in the December 2014 quarter at 271.48%. The ROE was at its lowest in in the June 2023 quarter at -52.64%.

Quarterly (TTM)
Annual

Average

-18.35%

Median

-22.99%

Minimum

-100.80%

Maximum

58.68%

OSE Immunotherapeutics S.A. (OSE.PA) ROE by Quarter and Year

Discovering the peaks and valleys of OSE Immunotherapeutics S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 239.92%

Maximum Annual ROE = 58.68%

Minimum Annual Increase = -189.46%

Minimum Annual ROE = -100.80%

Quarterly (TTM)
Annual
YearROEChange
202458.68%-158.22%
2023-100.80%84.72%
2022-54.57%55.09%
2021-35.18%30.15%
2020-27.03%239.92%
2019-7.95%-189.46%
20188.89%-146.93%
2017-18.94%-159.14%
201632.03%-183.03%
2015-38.57%-110.93%

OSE Immunotherapeutics S.A. (OSE.PA) Average ROE

How has OSE.PA ROE performed in the past?

The current ROE of OSE Immunotherapeutics S.A. (OSE.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-32.23%

5-year avg

-31.78%

10-year avg

-18.35%

OSE Immunotherapeutics S.A. (OSE.PA) ROE vs. Peers

How is OSE.PA’s ROE compared to its peers?

OSE Immunotherapeutics S.A.’s ROE is greater than ABIONYX Pharma S.A. (-71.55%), greater than Innate Pharma S.A. (-658.91%), greater than Sensorion S.A. (-43.50%), less than Adocia S.A. (180.00%), less than Crossject S.A. (477.00%), greater than Transgene S.A. (-634.16%), greater than Genfit S.A. (-63.70%), greater than MaaT Pharma S.A. (-334.21%), less than Median Technologies S.A. (59.08%), greater than Cellectis S.A. (-49.81%),

Build a custom stock screener for OSE Immunotherapeutics S.A. (OSE.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OSE Immunotherapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OSE Immunotherapeutics S.A. (OSE.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OSE Immunotherapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is OSE Immunotherapeutics S.A.'s ROE?

How is the ROE calculated for OSE Immunotherapeutics S.A. (OSE.PA)?

What is the highest ROE for OSE Immunotherapeutics S.A. (OSE.PA)?

What is the 3-year average ROE for OSE Immunotherapeutics S.A. (OSE.PA)?

What is the 5-year average ROE for OSE Immunotherapeutics S.A. (OSE.PA)?

How does the current ROE for OSE Immunotherapeutics S.A. (OSE.PA) compare to its historical average?